KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gsk (GSK) FCF Margin (2016 - 2025)

Historic FCF Margin for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to 33.12%.

  • Gsk's FCF Margin rose 24300.0% to 33.12% in Q3 2025 from the same period last year, while for Dec 2025 it was 43.11%, marking a year-over-year increase of 208000.0%. This contributed to the annual value of 29.51% for FY2024, which is 71500.0% up from last year.
  • As of Q3 2025, Gsk's FCF Margin stood at 33.12%, which was up 24300.0% from 33.67% recorded in Q2 2025.
  • Gsk's 5-year FCF Margin high stood at 42.87% for Q3 2021, and its period low was 7.48% during Q1 2023.
  • Its 5-year average for FCF Margin is 23.81%, with a median of 21.81% in 2024.
  • Data for Gsk's FCF Margin shows a peak YoY increase of 295300bps (in 2021) and a maximum YoY decrease of -1002000bps (in 2021) over the last 5 years.
  • Over the past 5 years, Gsk's FCF Margin (Quarter) stood at 10.42% in 2021, then skyrocketed by 96bps to 20.37% in 2022, then decreased by -15bps to 17.24% in 2023, then rose by 27bps to 21.81% in 2024, then skyrocketed by 52bps to 33.12% in 2025.
  • Its FCF Margin was 33.12% in Q3 2025, compared to 33.67% in Q2 2025 and 20.08% in Q1 2025.